Cannabinoid pathways may offer targets for kidney disease as CKD… | HappeningNow.news

Health · 58 views

Cannabinoid pathways may offer targets for kidney disease as CKD affects 850 million people

Approximately 850 million people globally (9.1% of the world's population) have chronic kidney disease (CKD). The number of affected individuals has grown steadily during the past 20 years and is on track to continue rising.

Source AI Summary Published July 31, 2026 Brief Under 1 min brief
Story intelligence
Coverage Single outlet Single-outlet story
Views 58 Community interest
Brief read Under 1 min brief 92 words

AI Summary

A study from the Autonomous University of Aguascalientes in Mexico suggests that cannabinoid pathways could be a new therapeutic target for chronic kidney disease (CKD). CKD currently affects about 850 million people worldwide, a number that has risen steadily over the past two decades and is expected to keep increasing. Current treatments such as RAAS inhibitors and angiotensin receptor blockers can slow progression but do not halt the disease, and their effectiveness varies among patients. The researchers discuss the potential of targeting cannabinoid signaling in a paper published in Frontiers in Pharmacology.

AI summaries can be wrong sometimes—always verify important details using the source article.

How AI & Automation are used
Read original at Medical Xpress

Coverage Context

Part of CKD coverage 16 tracked stories

More from Health

Continue reading recent Health coverage

Support HappeningNow

Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.

Support HappeningNow

Report an issue with this page